Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 3

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Total article views   HTML views PDF downloads Totals
14,591 Dovepress* 11,697+ 2,758 14,455
PubMed Central* 2,894 911 3,805
Totals 14,591 3,669 18,260
*Since 24 May 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 0 10

View citations on PubMed Central and Google Scholar